Glipizide Tablet, Extended Release while Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Glipizide Tablet, Extended Release while breastfeeding. We will also discuss about common side effects and warnings associated with Glipizide Tablet, Extended Release.

What is Glipizide Tablet, Extended Release used for?


Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Glipizide Tablet, Extended Release while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Glipizide Tablet, Extended Release safe for breastfeeding
As per our analysis Glipizide Tablet, Extended Release contains only one ingredient and that is Glipizide. We have analyzed Glipizide and it seems to be safe to use Glipizide while breastfeeding, that means usage of Glipizide Tablet, Extended Release shall be safe while breastfeeding. Below you can check more details of Glipizide usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.2 Lactation Risk Summary Breastfed infants of lactating women using glipizide extended-release tablets should be monitored for symptoms of hypoglycemia (see Clinical Considerations). Although glipizide was undetectable in human milk in one small clinical lactation study; this result is not conclusive because of the limitations of the assay used in the study. There are no data on the effects of glipizide on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for glipizide extended-release tablets and any potential adverse effects on the breastfed child from glipizide extended-release tablets or from the underlying maternal condition. Clinical Considerations Monitoring for adverse reactions Monitor breastfed infants for signs of hypoglycemia (e.g., jitters, cyanosis, apnea, hypothermia, excessive sleepiness, poor feeding, seizures).

Glipizide Tablet, Extended Release Breastfeeding Analsys


Glipizide while Breastfeeding

Safe

CAS Number: 29094-61-9

Sulfonilurea drugs stimulate secretion of endogen insulin. Oral anti-diabetic drugs are useless for treatment of diabetes type 1. For diabetes type 2, diet and exercise are advisable. Breastfeeding helps to lower glucemia level. See section on Maternal diabetes mellitus

Glipizide Tablet, Extended Release Breastfeeding Analsys - 2


Glipizide while Breastfeeding

CAS Number: 29094-61-9

Limited data indicate that the levels of glipizide in milk are low. However, an alternate drug for which there is more information may be preferred, especially while nursing a newborn or preterm infant. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with hypoglycemic agents.[1][2]


What should I do if already breastfed my kid after using Glipizide Tablet, Extended Release?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Glipizide Tablet, Extended Release and have used it then do not panic as Glipizide Tablet, Extended Release is mostly safe in breastfeeding and should not cause any harm to your baby.


I am nursing mother and my doctor has suggested me to use Glipizide Tablet, Extended Release, is it safe?

Usage of Glipizide Tablet, Extended Release is safe for nursing mothers and baby, No worries.


If I am using Glipizide Tablet, Extended Release, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Glipizide Tablet, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Glipizide Er Tablet, Film Coated, Extended Release
Glipizide Er | Glipizide Tablet, Extended Release